Sleep drug trial aims to calm suicidal thoughts in veterans
NCT ID NCT06854224
Summary
This small, early-stage study is testing whether a sleep medication called suvorexant is safe and tolerable for veterans with major depression and elevated suicide risk. Over four weeks, 30 participants will take the drug daily while researchers measure changes in suicidal thoughts, aggression, and attention. The goal is to see if targeting the brain's orexin system—involved in wakefulness and stress—might help ease dangerous mental states.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER (MDD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
James J. Peters Veterans Affairs Medical Center
RECRUITINGThe Bronx, New York, 10468, United States
Conditions
Explore the condition pages connected to this study.